GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors

Clinical trial NCT06435455 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06435455
Sponsor: Suzhou Genhouse Bio Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation

Start date: 2024-07-01
Primary completion: 2027-09-30
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.